User:Mr. Ibrahem/Albendazole

Albendazole, also known as albendazolum, is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among other diseases It is taken by mouth.

Common side effects include nausea, abdominal pains, and headaches. Potentially serious side effects include bone marrow suppression which usually improves on stopping the medication. Liver inflammation has been reported and those with prior liver problems are at greater risk. It is pregnancy category C in the United States and category D in Australia, meaning it may cause harm if taken by pregnant women. Albendazole is a broad-spectrum antihelminthic agent of the benzimidazole type.

Albendazole was developed in 1975. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is between 0.01 and US$0.06 per dose. In the United States, as of 2019, the wholesale cost is about US$128 per dose.